Skip to main content Skip to footer site map
  • DONATE

NJ Spotlight News | Clip | NJ becomes hub for development of COVID-19 drugs

A laboratory in north Jersey is now the hub where new COVID-19 treatments will be developed. The Metropolitan Antiviral Drug Accelerator Program, or MADVA, a partnership between scientists and drugmakers, is aimed at creating drugs that can be taken by mouth while patients' symptoms of COVID-19 are still mild.

0:04:34 | AIRED: 5/31/2022 |
THIRTEEN Passport | A benefit of membership | Activate Now
Membership Promo

NEWSLETTER SIGNUP

CONNECT WITH THIRTEEN